Outlook Therapeutics market cap OTLK
Share price times shares outstanding: what the whole company sells for, since 2016.
- Today, Nov 2, 2026
- $114.2M
- Highest close in our data
- $465.3M
- May 2021
Outlook Therapeutics is worth $114.2M at the close on Nov 2, 2026, at $0.47 a share.
That is up 116% over the last year and down 69% over five years.
Its highest close in our data was $465.3M in May 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $114.2M | $17.3M | $206.7M | −2% |
| 2025 | $116.7M | $37.8M | $119M | +145% |
| 2024 | $47.5M | $34.1M | $205.5M | −54% |
| 2023 | $102.5M | $53M | $464.6M | −58% |
| 2022 | $246.5M | $205.8M | $450.8M | −19% |
| 2021 | $305M | $118.9M | $465.3M | +84% |
| 2020 | $165.3M | $23.8M | $197.1M | +920% |
| 2019 | $16.2M | $14.1M | $123.6M | −62% |
| 2018 | $42.5M | $22.9M | $70.8M | +33% |
| 2017 | $32.1M | $21.2M | $88.2M | −55% |
| 2016 | $71M | $43.2M | $119.7M | n/a |
Against its peers
Companies in Healthcare nearest Outlook Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| OTLKOutlook Therapeutics | $114.2M |
| KEQUKewaunee Scientific | $96.7M |
| ICCCImmucell | $95.9M |
| LFVNLifevantage | $73.5M |
| PDEXPro DEX | $184.5M |
| PLXProtalix BioTherapeutics | $206.3M |
| NATRNatures Sunshine Products | $211.5M |
| SPROSpero Therapeutics | $60.6M |
| ELMDElectromed | $223.9M |
| UTMDUtah Medical Products | $224.6M |
| APTAlpha Pro Tech | $56.3M |
| Peer median | $140.6M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Outlook Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.